Molecmo Nanobiotechnologies Cambridge, MA - 02138

Molecmo Nanobiotechnologies is categorized under Research and Development Laboratories in Cambridge, MA and active since 2006.

Molecmo Nanobiotechnologies was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Ali Munawar at the company’s single location by writing to 375 Harvard St Apartment 28, Cambridge, Massachusetts MA 02138 or by phoning (617) 308-3836. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Molecmo Nanobiotechnologies
Contact Person: Ali Munawar
Address: 375 Harvard St Apartment 28, Cambridge, Massachusetts 02138
Phone Number: (617) 308-3836
Annual Revenue (USD): $100.000 to $499.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Molecmo Nanobiotechnologies was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ali Munawar for inquiries that concern Molecmo Nanobiotechnologies by calling the company number (617) 308-3836, as your correspondence is most welcome. Additionally, the physical location of the single location of Molecmo Nanobiotechnologies can be found at the coordinates as well as the street address 375 Harvard St Apartment 28 in Cambridge, Massachusetts 02138.

For its online presence, you may visit Molecmo Nanobiotechnologies’s website at and engage with its social media outlets through on Twitter and on Facebook.